Answer
The selected product is licensed for adults and adolescents aged 12 years and over with persistent asthma. Safety and effectiveness below this age have not been established.
Sources for this answer
- Alvesco 160 Inhaler — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.